Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

November 2, 2014

Primary Completion Date

December 30, 2015

Study Completion Date

October 30, 2016

Conditions
Herpes Zoster Pain
Interventions
DRUG

5% Lidocaine patch

5% Lidocaine patch to be placed on the site of pain

DRUG

Placebo

Placebo patch to be placed on the site of pain

Trial Locations (21)

100044

Beijing University People's Hospital, Beijing

Unknown

Air force general hospital, Beijing

Beijing friendship hospital, Beijing

Beijing university first hospital, Beijing

Beijing university third hospital, Beijing

The first affiliated hospital of Jilin university, Changchun

Xiangya hospital central south university, Changsha

South West Hospital, Chengdu

First affiliated hospital of Chongqing medical university, Chongqing

The first affiliated hospital of Dalian university, Dalian

Guangzhou general hospital, Guangzhou

The first affiliated hospital of Zhejiang university, Hangzhou

Shandong dermatology hospital, Jinan

The second affiliated hospital of Kunming medical college, Kunming

China dermatology research center, Nanjing

Shanghai Huashan hospital, Shanghai

Shanghai Ruijin Hospital, Shanghai

Shengjing Hospital, Shenyang

The fourth affiliated hospital of Hebei medical university, Shijiazhuang

General hospital of Tianjin medical university, Tianjin

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Mundipharma (China) Pharmaceutical Co. Ltd

INDUSTRY

NCT02452112 - Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain | Biotech Hunter | Biotech Hunter